Finally, MEDI2228 is an ADC composed of a fully human anti-BCMA antibody conjugated to a pyrrolobenzodiazepine dimer with potent in vitro and in vivo anti-MM activity in murine models [45]. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.